SynthesisMolecular diagnosis & therapy2022

Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic Review.

Míriam Campistol et al.PubMed ↗Publisher ↗

No numbers read from the abstract.